SPRY4 and osteosarcoma: Notably, no inhibitory effect of ectopic expression of SPRY4 on proliferation was observed in osteosarcoma-derived cells, possibly because the activation of the MAPK/ERK pathway in osteosarcoma cells is not primarily dependent on the regulation of SPRY4 (30).